Isotopen Technologien München is a privately held biotechnology and radiopharmaceutical group of companies.

Biotechnology

Isotopen Technologien München

Isotopen Technologien München's headquarters in Garching, Germany

Andrew Cavey

Richard Henkelmann

Manuel Salvisberg

Gunther Strothe

Stefan Sanktjohanser

Tadd Wessel

Oliver Buck

Udo J. Vetter

Michael Lee-Chin

This department ensures that products meet established quality standards through systematic testing and evaluation processes.

Quality Assurance

This department oversees the development, management, and compliance of clinical operations and regulatory strategies in the pharmaceutical sector.

Clinical and Regulatory Affairs

This department oversees the planning, execution, and monitoring of clinical trials to ensure compliance and efficiency.

Clinical Trial Management

This department focuses on managing key accounts and accessing global markets for products and services.

Market Access Management

The Clinical Operations Team at Isotopen Technologien München oversees the planning, execution, and management of clinical trials for radiopharmaceutical products. They ensure compliance with regulatory standards, coordinate with global regulatory bodies, and manage alliances to advance clinical development. This team plays a pivotal role in translating innovative research into effective treatments.

Clinical Operations Team

This department is responsible for overseeing and ensuring the quality and compliance of material specifications.

Isotopen Technologien München

Org chart

Board & advisors

Teams

Quality Assurance

Clinical and Regulatory Affairs

Clinical Trial Management

Market Access Management

Clinical Operations Team

Quality Control

Offices

Isotopen Technologien München

Org chart

Board & advisors

Teams

Quality Assurance

Clinical and Regulatory Affairs

Clinical Trial Management

Market Access Management

Clinical Operations Team

Quality Control

Offices

Related companies